Skip to main content
. 2022 Mar 17;122(7):1545–1557. doi: 10.1007/s00421-022-04927-1

Table 2.

PEDro scale of the included studies; * = was not counted for the final score; 1 = one point awarded; 0 = no point awarded

Study Inclusion criteria Random allocation Concealed allocation Similarity at baseline Subject blinding Therapist blinding Assessor blinding  >85% follow-up Intention to treat analysis Between-group comparison Point estimates and variability Total
Smith et al. (2018) 1 1 0 1 1 0 0 1 1 1 1 7
Behara and Jacobson (2017) 1 1 0 1 1 0 0 1 1 1 1 7
Su et al. (2017) 1 1 0 1 1 0 0 1 1 1 1 7
Fairall et al. (2017) 1 1 0 1 0 0 0 1 1 1 1 6
Škarabot et al. (2015) 1 1 1 1 0 0 0 1 1 1 1 7
Lee et al. (2018) 1 1 0 1 1 0 0 1 1 1 1 7
Lyu et al. (2020) 1 1 0 1 1 0 0 1 1 1 1 7
Folli et al. (2021) 1 1 0 1 1 0 0 1 1 1 1 7
Penichet-Tomas et al. (2021) 1 0 0 1 0 0 0 1 1 1 0 4
Lopez-Samanes et al. (2021) 1 1 0 1 1 0 0 1 1 1 1 7
Connolly et al. (2020) 1 1 0 1 1 0 0 1 1 1 1 7
Zaky et al. (2021) 0 0 0 1 0 0 0 1 1 1 0 4
Krause et al. (2018) 1 1 0 1 0 0 0 1 1 1 1 6
Sagiroglu et al. (2017) 1 1 0 1 1 0 0 1 1 1 1 7
Halperin et al. (2014) 1 1 0 1 1 0 0 1 1 1 1 7
Monteiro et al. (2018) 1 1 0 1 0 0 1 1 1 1 0 6
Somers et al. (2020) 1 1 1 1 0 1 1 1 1 1 1 9
Smith et al. (2019) 0 1 1 1 0 1 1 1 0 1 0 7
Pepper et al. (2021) 1 1 0 1 0 1 1 1 1 1 0 7
Mohr et al. (2014) 1 1 0 1 0 0 0 1 1 1 1 6